WHO ICTRP trial
INTermittent ERythromycin versus Infusion: Comparative study in the critically…
ACTRN12615001271594 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12615001271594 |
|---|---|
| Public title | INTermittent ERythromycin versus Infusion: Comparative study in the critically ill (INTERIC study). |
| Scientific title | Intermittent versus infusion of Erythromycin for feeding tolerability in the critically ill. |
| Primary sponsor | Flinders Medical Centre |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Australia |
| Conditions | Feeding intolerability in the critically ill patients.; Feeding intolerability in the critically ill patients.;Diet and Nutrition - Other diet and nutrition disorders |
| Interventions | The intervention group is the 'continuous infusion" group. This group will receive 250 mg of erythromycin in 50 ml of saline as a continuous intravenous infusion (2ml/hr) and in addition, intermittent single dose infusion of 50 ml of saline… |
| Registration date | Nov 20, 2015 |
| Target size | 40 |
| Secondary IDs | Nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: